The TGF-β1 activation indices were similar between patients and control individuals (median [interquartile range] AI: 1.63 [1.31–1.88] in SLE patients versus 1.50 [1.26–1.73] in control individuals, P = 0.157; data not shown). Here, TGFB1 is linked to systemic lupus erythematosus.